Presentation is loading. Please wait.

Presentation is loading. Please wait.

Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies. Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies.

Published byFelicity McBride Modified over 5 years ago

Similar presentations

Presentation on theme: "Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies. Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies."— Presentation transcript:

1 Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies.
Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies. Six-month weight loss values and A1C values for the ILI and DSE groups were not published as individual data points. Eight-year A1C values are estimated from a published chart (1) because data were not presented in tables elsewhere. mos, months; mtg, meeting; PCP, primary care provider. Meg G. Salvia Diabetes Spectr 2017;30: ©2017 by American Diabetes Association

Download ppt "Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies. Weight loss and A1C reduction over time in the Look AHEAD and IDOLc studies."

Similar presentations

1 times table 2 times table 3 times table 4 times table 5 times table

1 times table 2 times table 3 times table 4 times table 5 times table
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.

Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Background  Obesity is an extremely common problem ~ 1/3 of adult Americans are obese  Patients commonly ask physicians for advice on weight loss, yet.

Background  Obesity is an extremely common problem ~ 1/3 of adult Americans are obese  Patients commonly ask physicians for advice on weight loss, yet.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 2 of 4.

Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 2 of 4.
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
Tables Learning Support

Tables Learning Support
The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92:308-315 - DOI:10.1159/000450555.

The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92: DOI: /
Times Tables.

Times Tables.
Bob Stewart, a retired podiatrist with type 1 diabetes who, at age 95, set two world records in the 95+ age-group at the Senior Olympics and knew a thing.

Bob Stewart, a retired podiatrist with type 1 diabetes who, at age 95, set two world records in the 95+ age-group at the Senior Olympics and knew a thing.
Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight change. Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight.

Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight change. Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight.
Current Therapy for Type II Diabetes

Current Therapy for Type II Diabetes
Rate of provision of PCC

Rate of provision of PCC
Estimated Number of Cancer Cases (in Thousands) Attributable to Excess Body Mass

Estimated Number of Cancer Cases (in Thousands) Attributable to Excess Body Mass
The Long-term Effectiveness of a Lifestyle Intervention in Severely Obese Individuals  Jessica L. Unick, PhD, Daniel Beavers, PhD, Dale S. Bond, PhD, Jeanne.

The Long-term Effectiveness of a Lifestyle Intervention in Severely Obese Individuals  Jessica L. Unick, PhD, Daniel Beavers, PhD, Dale S. Bond, PhD, Jeanne.
Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.

Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.
Powerpoint charts from Tables and charts

Powerpoint charts from Tables and charts
Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.

Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.
Antihyperglycemic therapy in type 2 diabetes: general recommendations

Antihyperglycemic therapy in type 2 diabetes: general recommendations
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
PWD who regularly or occasionally engaged in activities to manage their diabetes. PWD who regularly or occasionally engaged in activities to manage their.

PWD who regularly or occasionally engaged in activities to manage their diabetes. PWD who regularly or occasionally engaged in activities to manage their.

Similar presentations

Ads by Google